Literature DB >> 16230097

No role of the -2518 promoter polymorphism of monocyte chemotactic protein-1 in chronic hepatitis C.

Herbert L Bonkovsky, Jefrey Salek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16230097     DOI： 10.1053/j.gastro.2005.08.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial.

Authors:  Timothy R Morgan; Richard W Lambrecht; Herbert L Bonkovsky; Raymond T Chung; Deepa Naishadham; Richard K Sterling; Robert J Fontana; William M Lee; Marc G Ghany; Elizabeth C Wright; Thomas R O'Brien
Journal:  J Hepatol       Date:  2008-06-05       Impact factor: 25.083

2.  Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.

Authors:  Yonghong Li; Monica Chang; Olivia Abar; Veronica Garcia; Charles Rowland; Joseph Catanese; David Ross; Samuel Broder; Mitchell Shiffman; Ramsey Cheung; Teresa Wright; Scott L Friedman; John Sninsky
Journal:  J Hepatol       Date:  2009-06-18       Impact factor: 25.083

Review 3.  Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.

Authors:  Julie R Jonsson; David M Purdie; Andrew D Clouston; Elizabeth E Powell
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.